Table 3.
Comparison of PFT Parameters between RNMB-present (TOF less than 0.9 at PFT) and RNMB-absent Patients within the Groups and RNMB-present (TOF less than 0.9 at PFT) Patients across Vecuronium, Atracurium, and Rocuronium Groups
Comparison of PFT Parameters between RNMB-present (TOF less than 0.9 at PFT) and RNMB-absent Patients within the Groups and RNMB-present (TOF less than 0.9 at PFT) Patients across Vecuronium, Atracurium, and Rocuronium Groups
